药物诱导的肝脏损伤
1Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, 1008 West Hazelwood Drive, Urbana, IL 61802, USA.
概括
药物诱导性肝损伤 (DILI) 是物肝损伤的常见原因之一. 识别狗和猫的DILI需要兽医的怀疑,详细的药物史,并了解药物毒性,以确保适当的诊断和治疗.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 毒理学 毒理学 毒理学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 药物诱导性肝损伤 (DILI) 是小动物肝病的一个未被认可的原因.
- 准确的诊断依赖于兽医的怀疑,全面的药物暴露史,以及对药物毒性的知识.
- 本综述涉及狗和猫的DILI,涵盖病变发生,分类和诊断.
研究的目的:
- 审查小动物中DILI的发病,分类和诊断.
- 讨论与特定兽药药物相关的DILI的临床表现,患病率和结果.
- 评估营养品和草药制剂在引起DILI的毒性潜力.
主要方法:
- 在兽医中对DILI的文献综述.
- 对各种药物的临床表现,患病率和结果的分析.
- 对常见的兽医药物,营养品和草药的毒理学数据的评估.
主要成果:
- 在兽医中,DILI是一个重要的关注点,通常与特定药物有关.
- 涉及的关键药物包括阿扎西奥普林,阿佐尔抗真菌药物,卡普罗芬,迪亚泽帕姆,多克西环素,洛穆斯丁,甲基马,诺巴比塔尔,里法,硫胺和佐尼萨米德.
- 营养药品和草药产品也构成DILI的风险.
结论:
- 早期识别和理解药物毒性对于管理物DILI至关重要.
- 兽医必须在诊断肝病时考虑DILI,特别是在药物管理后.
- 对DILI机制和更安全的药物替代品的进一步研究是有必要的.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
94
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
94
Diseases of the Liver and Gallbladder
345
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
345
Hepatic Drug Excretion: Enterohepatic Cycling
809
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
809
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Drug Metabolism: Phase I Reactions
2.9K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
2.9K
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K


